Suprathreshold levodopa doses, dyskinesias, and disability in advanced Parkinson's disease

Neurology. 1998 Aug;51(2):649-50. doi: 10.1212/wnl.51.2.649.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antiparkinson Agents / therapeutic use*
  • Disabled Persons*
  • Dose-Response Relationship, Drug
  • Dyskinesia, Drug-Induced / etiology*
  • Humans
  • Levodopa / therapeutic use*
  • Parkinson Disease / drug therapy*
  • Retrospective Studies

Substances

  • Antiparkinson Agents
  • Levodopa